, the multidisciplinary practice of Baylor College of Medicine, has received Gold+ and Silver recognition and Gold recognition from the American Heart Association. These awards acknowledge the specialties’ and practices’ commitment to decreasing the number of Americans living with uncontrolled blood pressure and reducing the risk of heart disease and stroke through improved cholesterol management, respectively.
“We are delighted that several of our clinics were recognized by the American Heart Association for their efforts in improving blood pressure and cholesterol control,” said , chief quality officer of Baylor Medicine and medical director of the Baylor Medicine General Internal Medicine Clinic. “These awards highlight our dedication to the quality of care we deliver for our patients.”
The Baylor Medicine specialty that received the Target: BP™ Gold+ Achievement Award is Baylor Medicine Cardiology at Fannin Tower. The Target: BP™ Gold+ award recognizes practices that demonstrate a commitment to measurement accuracy and achieve blood pressure control in 70% or more of adult patients with hypertension.
The Baylor Medicine specialties and clinics that received the Target: BP™ Silver Achievement Award are:
- Baylor Medicine Atherosclerosis
- Baylor Medicine Comprehensive Health Clinic
- Baylor Medicine Cardiology at McNair
- Baylor Medicine Endocrinology
- Baylor Medicine Gastroenterology
- Baylor Medicine General Internal Medicine
- Baylor Medicine Geriatrics
- Baylor Medicine Infectious Disease
- Baylor Medicine Nephrology
- Baylor Medicine Pulmonary
- Baylor Medicine Rheumatology
- Baylor Medicine Family Medicine – Kirby
- Baylor Medicine Family Medicine – River Oaks
- Baylor Medicine Family Medicine – Fannin Tower (Texas Medical Center)
The Target: BP™ Silver award recognizes practices that have demonstrated a commitment to improving blood pressure control through measurement accuracy.
The Baylor Medicine specialties and clinics that received the Check. Change. Control. Cholesterol™ Gold Achievement Award are:
- Baylor Medicine Cardiology at Fannin Tower
- Baylor Medicine Atherosclerosis
- Baylor Medicine Cardiology at McNair
- Baylor Medicine Endocrinology
- Baylor Medicine General Internal Medicine
- Baylor Medicine Geriatrics
The Check. Change. Control. Cholesterol™ Gold award recognizes practices that appropriately manage with statin therapy at least 70% of their adult patients at high risk of atherosclerotic cardiovascular disease.
Target: BP™ is a national initiative formed by the American Heart Association and the American Medical Association in response to the high prevalence of uncontrolled blood pressure (BP). Target: BP helps healthcare organizations and care teams, at no cost, improve BP control rates through an evidence-based quality improvement program and recognizes organizations committed to improving BP control. The American Heart Association created the Check. Change. Control. Cholesterol™ initiative with national support from Amgen to improve awareness, detection and management of high cholesterol for consumers, patients and healthcare professionals.
“Cardiovascular disease remains the leading cause of death in the United States, and uncontrolled hypertension and cholesterol both contribute to this,” Murphy said. “By optimizing blood pressure and cholesterol, we can reduce the risk of heart attacks, strokes and other cardiovascular events and help our patients live longer and healthier lives.”
